Can Startup Prediction Sciences Prescribe a Cure for the Wrong-Antidepressant Blues? | GenomeWeb

At last week’s annual LabAutomation Conference, pharmacogenomics was a sizzling buzzword. It was also one of those areas where many attendees said they wanted to get into, but few professed to know much about.

Still, by the time the conference wound up last Wednesday, few attendees hung around to hear Chris Herold, of San Diego startup Prediction Sciences, discuss the pharmacogenomics technology he hopes will turn the world of blockbuster antidepressants on its head.

Those who left early might just regret not staying.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.